标题
G2019S Variation in LRRK2: An Ideal Model for the Study of Parkinson’s Disease?
作者
关键词
-
出版物
Frontiers in Human Neuroscience
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-09-04
DOI
10.3389/fnhum.2019.00306
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders?
- (2019) Tiago Fleming Outeiro et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The impact of murine LRRK2 G2019S transgene overexpression on acute responses to inflammatory challenge
- (2018) Darcy Litteljohn et al. BRAIN BEHAVIOR AND IMMUNITY
- CSF lamp2 concentrations are decreased in female Parkinson’s disease patients with LRRK2 mutations
- (2018) Andrea C. Klaver et al. BRAIN RESEARCH
- Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls
- (2018) Steven A. Gunzler et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study
- (2018) Tiago A. Mestre et al. MOVEMENT DISORDERS
- α-synuclein (SNCA ) but not dynamin 3 (DNM3 ) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain
- (2018) Rubén Fernández-Santiago et al. MOVEMENT DISORDERS
- Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson’s disease
- (2018) Kwang Soo Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vitro Modeling of Leucine-Rich Repeat Kinase 2 G2019S-Mediated Parkinson's Disease Pathology
- (2018) Scott C. Vermilyea et al. STEM CELLS AND DEVELOPMENT
- No association of DNM3 with age of onset in Asian Parkinson's disease
- (2018) J. N. Foo et al. EUROPEAN JOURNAL OF NEUROLOGY
- LRRK2 activation in idiopathic Parkinson’s disease
- (2018) Roberto Di Maio et al. Science Translational Medicine
- Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease
- (2017) Andrew B. West EXPERIMENTAL NEUROLOGY
- LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson’s disease
- (2017) Evan H Howlett et al. HUMAN MOLECULAR GENETICS
- Alterations in the reduced pteridine contents in the cerebrospinal fluids of LRRK2 mutation carriers and patients with Parkinson’s disease
- (2017) Hiroshi Ichinose et al. JOURNAL OF NEURAL TRANSMISSION
- Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease
- (2017) María Sierra et al. NEUROLOGY
- DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers
- (2017) Moran Artzi et al. PLoS One
- Timeline: iPSCs—The First Decade
- (2016) Sheila Chari et al. CELL
- Lovastatin protects neurite degeneration inLRRK2-G2019Sparkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity
- (2016) Chin-Hsien Lin et al. HUMAN MOLECULAR GENETICS
- LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurotoxicity
- (2016) Senthilkumar S. Karuppagounder et al. JOURNAL OF CHEMICAL NEUROANATOMY
- Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1
- (2016) Bumpei Samata et al. Nature Communications
- Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson’s Disease-Related LRRK2 G2019S Mutation
- (2015) Andrew J. Schwab et al. Stem Cell Reports
- Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology
- (2014) Francisco Pan-Montojo et al. Translational Neurodegeneration
- Genetic Correction of a LRRK2 Mutation in Human iPSCs Links Parkinsonian Neurodegeneration to ERK-Dependent Changes in Gene Expression
- (2013) Peter Reinhardt et al. Cell Stem Cell
- Parkinson disease phenotype in Ashkenazi jews with and withoutLRRK2G2019S mutations
- (2013) Roy N. Alcalay et al. MOVEMENT DISORDERS
- LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction
- (2013) Laurie H. Sanders et al. NEUROBIOLOGY OF DISEASE
- The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: Clinical and demographic characteristics
- (2013) Emilia Mabel Gatto et al. NEUROSCIENCE LETTERS
- Progressive degeneration of human neural stem cells caused by pathogenic LRRK2
- (2012) Guang-Hui Liu et al. NATURE
- Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson's Disease
- (2012) O. Cooper et al. Science Translational Medicine
- Small Molecules Greatly Improve Conversion of Human-Induced Pluripotent Stem Cells to the Neuronal Lineage
- (2012) Sally K. Mak et al. Stem Cells International
- LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
- (2011) Ha Nam Nguyen et al. Cell Stem Cell
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
- (2011) Xianming Deng et al. Nature Chemical Biology
- The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
- (2010) Mark R. Cookson NATURE REVIEWS NEUROSCIENCE
- LRRK2 G2019S mutation in Parkinson’s disease: A neuropsychological and neuropsychiatric study in a large Algerian cohort
- (2010) Soreya Belarbi et al. PARKINSONISM & RELATED DISORDERS
- Genetic factors involved in the pathogenesis of Parkinson's disease
- (2008) Frank J.S. Lee et al. BRAIN RESEARCH REVIEWS
- Disease-Specific Induced Pluripotent Stem Cells
- (2008) In-Hyun Park et al. CELL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started